Nutrition and health

Objectives:
The association between elevated serum phosphorus concentration and cardiovascular or all-cause mortality yielded conflicting results. Therefore, this review article (meta-analysis) has been conducted.

Does an elevated serum phosphorus concentration increase cardiovascular and all-cause mortality in the general population?

Study design:
This review article included 6 prospective cohort studies involving 120,269 subjects.

Results and conclusions:
The investigators found when compared the highest with the reference concentration of serum phosphorus, a significant increased risk of 36% for cardiovascular mortality [pooled RR = 1.36, 95% CI = 1.07-1.72]. Significant because RR of 1 was not found in the 95% CI of 1.07 to 1.72. RR of 1 means no risk/association.

The investigators found when compared the highest with the reference concentration of serum phosphorus, a significant increased risk of 33% for all-cause mortality [pooled RR = 1.33, 95% CI = 1.15-1.58]. Significant means that there is an association with a 95% confidence.

The investigators found stratified analyses revealed that elevated serum phosphorus significantly increased all-cause mortality risk with 33% among men [RR 1.33, 95% CI = 1.11-1.60], but not in women [RR = 1.09, 95% CI = 0.89-1.33].

The investigators concluded elevated serum phosphorus concentration is independently associated with excessive risk of cardiovascular and all-cause mortality in the general population without chronic kidney disease. Serum phosphorus on all-cause mortality risk appears to be pronounced in men but exhibits no clear effect on women. However, gender difference of elevated serum phosphorus on mortality risk should be verified by more prospective cohort studies.

Original title:
Serum phosphorus, cardiovascular and all-cause mortality in the general population: A meta-analysis by Bai W, Li J and Liu J.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/27475981

Additional information of El Mondo:
Find more studies/information on elderly and phosphorus right here.

Objectives:
Does garlic supplementation reduce cardiovascular disease risk?

Study design:
This review article included original studies and previous review articles (meta-analyses).

Results and conclusions:
The investigators found in 4 meta-analyses and 2 original studies that garlic supplementation significantly reduced blood pressure by 7-16 mmHg (systolic) and 5-9 mmHg (diastolic). Significant means that there is an association with a 95% confidence.

The investigators found in 8 meta-analyses that garlic supplementation significantly reduced total cholesterol by 7.4-29.8 mg/dL.

The most consistent benefits were shown in studies that used aged garlic extract (AGE).

The investigators found a few small studies that used aged garlic extract also showed favourable effects on C-reactive protein (CRP), pulse wave velocity (PWV), and coronary artery calcium (CAC).

Although garlic is generally safe, rare adverse reactions have been documented with limited causality established.

The investigators concluded garlic supplementation has the potential for cardiovascular protection based on risk factor reduction (hypertension and total cholesterol) and surrogate markers (C-reactive protein, pulse wave velocity and coronary artery calcium) of atherosclerosis. Larger studies are warranted to evaluate these effects further.

Original title:
Garlic and Heart Disease by Varshney R and Budoff MJ.

Link:
http://jn.nutrition.org/content/146/2/416S.long

Additional information of El Mondo:
Find more information/studies on garlic consumption and cardiovascular disease right here.

Objectives:
Increasing evidence suggests that the Mediterranean diet can reduce the risk of cardiovascular disease. Olive oil is the hallmark of this dietary pattern. Therefore, this review article has been conducted.

Does olive oil consumption reduce risk of cardiovascular disease?

Study design:
This review article included case-control, prospective cohort studies and a randomised controlled trial investigating the specific association between olive oil consumption and the risk of cardiovascular disease (101,460 participants) or stroke (38,673 participants). The results of all observational studies were adjusted for total energy intake.

Evidence of heterogeneity was apparent for cardiovascular disease, but not for stroke. Both the Egger test (p = 0.06) and the funnel plot suggested small-study effects.

Results and conclusions:
The investigators found in case-controle studies a non-significant reduced risk of 27% [relative risk = 0.73, 95% CI = 0.44-1.21] for cardiovascular disease for a 25g increase in olive oil consumption.

The investigators found in cohort studies a non-significant reduced risk of 4% [relative risk = 0.96, 95% CI = 0.78-1.18] for cardiovascular disease for a 25g increase in olive oil consumption.

The investigators found in cohort studies olive oil consumption significantly reduced risk of stroke with 26% [relative risk = 0.74, 95% CI = 0.60-0.92].

The investigators found random-effects model showed a significant reduced risk of 18% [RR = 0.82, 95% CI = 0.70, 0.96] for combining all cardiovascular events (CHD and stroke).

The investigators concluded available studies support an inverse association of olive oil consumption with stroke and with stroke and cardiovascular disease combined. This finding is in agreement with the recent successful results of the PREDIMED randomised controlled trial.

Original title:
Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case-control, cohort and intervention studies by Martínez-González MA, Dominguez LJ and Delgado-Rodríguez M.

Link:
https://www.ncbi.nlm.nih.gov/pubmed/24775425

Additional information of El Mondo:
Find more studies/information on cardiovascular disease right here.

Objectives:
What is the impact of antioxidants (N-acetylcysteine (NAC), polyunsaturated fatty acids (PUFAs) and vitamins) on incidence of postoperative atrial fibrillation (POAF) and duration of length of hospital stay?

Study design:
This review article included 23 RCTs that reported outcomes of 4278 patients undergoing cardiac surgery.
A total of 10 RCTs with 1,026 patients (513 cases were allocated to the NAC and 513 cases to the control group, with a mean age of 63.2 years and 76.8% being males), 8 RCTs with 2,687 patients (with a mean age of 64.17 years and 77.6% being males), and 5 RCTs with 565 patients (with a mean age of 65.17 years and 73.6% being males) investigated the effect of NAC, PUFA and antioxidant vitamins on POAF, respectively.

There was no publication bias.

Results and conclusions:
The investigators found pooled effects estimates on postoperative atrial fibrillation showed a significant reduction after:
NAC [OR = 0.56, 95% CI = 0.40-0.77, p 0.001, I2 = 15%, p = 0.3];
PUFA [OR = 0.84, 95% CI = 0.71-0.99, p = 0.03] and;
Vitamin C treatment [OR = 0.50, 95% CI = 0.27-0.91, p = 0.02, I2 = 50%].

The investigators found hospital length of stay was not significant reduced after NAC therapy [SMD = 0.082, 95% CI = -0.09 to 0.25, p = 0.3, I2 = 0.0%, p = 0.7], but could be significant decreased with PUFA [SMD = -0.185, 95% CI = -0.35 to -0.018, p = 0.03, I2 = 11%, p = 0.3] and vitamin C [SMD = -0.325, 95% CI = -0.50 to -0.14, p 0.01, I2 = 60.4%, p = 0.056].
Significant because the p-values were less than the p-value of 0.05.

The investigators concluded perioperative antioxidant supplementations with N-acetylcysteine, polyunsaturated fatty acids and vitamin C prevent atrial fibrillation after cardiac surgery. Moreover, polyunsaturated fatty acids and vitamin C are capable to reduce hospital stay, whereas N-acetylcysteine lacks this capacity.

Original title:
Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials by Ali-Hassan-Sayegha S, Mirhosseinia SJ, […], Liakopoulose OJ.

Link:
http://icvts.oxfordjournals.org/content/early/2014/02/19/icvts.ivu020.long

Additional information of El Mondo:
Find more studies on cardiovascular diseases, antioxidants, NAC, PUFA, vitamin C and p-value of 0.05/95% CI right here.